12
Nov 2026
Emotional and spiritual support vital for children in palliative care
A systematic review conducted by researchers at the University of Eastern Finland brings together studies from mainland China and Taiwan.
12
Nov 2026
A systematic review conducted by researchers at the University of Eastern Finland brings together studies from mainland China and Taiwan.
12
Nov 2026
2026 has been an unusually severe and active year for food safety issues, particularly when measured by outbreak case counts and recall volume by weight.
12
Nov 2026
Triple-negative breast cancer, which accounts for approximately 10–15% of all breast cancer cases, is considered particularly difficult to treat because it grows rapidly and carries a high risk of recurrence.
12
Nov 2026
Affecting 200 million women of reproductive age, endometriosis is a chronic inflammatory disease that causes pain, infertility, and increased ovarian cancer risk.
12
Nov 2026
On an organ-on-a-chip researchers can now explore how tumours grow and interact with their surroundings.
12
Nov 2026
Whether you hunch over a computer or spend hours scrolling on your phone, everyday habits can be a real pain in the neck. But when that pain persists, it can take a serious toll on everyday life, affecting everything from work and sleep to physical activity and wellbeing.
12
Nov 2026
An after dinner or bedtime snack can be hard to resist, but could a gentle nudge from a smartphone app help people with type two diabetes to quit the common habit?
12
Nov 2026
Orexo AB and SVF Vaccines AB today announced a research collaboration to investigate whether Orexo’s proprietary powder-based drug delivery technology, AmorphOX®, can be used to develop stable powder-based formulations of lipid nanoparticle (LNP)-encapsulated messenger RNA (mRNA) vaccines.
12
Nov 2026
Richmond Pharmacology, a specialist early-phase clinical research organization, has announced encouraging results from a first-in-human clinical trial evaluating CIDEBsiRNA, an investigational RNA interference (RNAi) therapy developed by Regeneron Pharmaceuticals, Inc.
12
Nov 2026
Frontotemporal dementia often results in early changes in personality or behavior before changes in cognitive skills.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more